Ceftriaxone Sodium Injection
Last Updated: July 10, 2017
Status: Current
Ceftriaxone Sodium Injection
Products Affected - Description
-
Ceftriaxone injection, Apotex
1 gram, vial, 10 count (NDC 60505-0752-04)
2 gram, vial, 10 count (NDC 60505-0753-04)
10 gram, vial, 1 count (NDC 60505-0679-05)
250 mg, vial, 10 count (NDC 60505-0750-04)
500 mg, vial, 10 count (NDC 60505-0751-00)
250 mg, vial, 10 count (NDC 60505-0750-04)
500 mg, vial, 10 count (NDC 60505-0751-00)
Ceftriaxone injection, Fresenius Kabi
500 mg, vial, 25 count (NDC 63323-0345-10)
Ceftriaxone injection, Lupin
1 gram, vial, 10 count (NDC 68180-0633-10)
1 gram, vial, 10 count (NDC 68180-0633-10)
2 gram, vial, 10 count (NDC 68180-0644-10)
250 mg, vial, 10 count (NDC 68180-0611-10)
500 mg, vial, 10 count (NDC 68180-0622-10)
Ceftriaxone injection, Pfizer
2 gram, ADD-Vantage vial, 10 count (NDC 00409-7336-04)
2 gram, ADD-Vantage vial, 10 count (NDC 00409-7336-04)
Ceftriaxone injection, Sandoz
1 gram, vial, 10 count (NDC 00781-3208-95)
1 gram, vial, 10 count (NDC 00781-3208-95)
Ceftriaxone injection, West-Ward
1 gram, vial, 25 count (NDC 00143-9857-25)
1 gram, vial, 25 count (NDC 00143-9857-25)
2 gram, vial, 25 count (NDC 00143-9856-25)
250 mg, vial, 25 count (NDC 00143-9859-25)
Ceftriaxone injection, Wockhardt USA
1 gram, vial, 10 count (NDC 64679-0983-02) - discontinued
2 gram, vial, 10 count (NDC 64679-0703-01) - discontinued
250 mg, vial, 10 count (NDC 64679-0701-02) - discontinued
500 mg, vial, 10 count (NDC 64679-0702-02) - discontinued
1 gram, vial, 10 count (NDC 64679-0983-02) - discontinued
2 gram, vial, 10 count (NDC 64679-0703-01) - discontinued
250 mg, vial, 10 count (NDC 64679-0701-02) - discontinued
500 mg, vial, 10 count (NDC 64679-0702-02) - discontinued
Reason for the Shortage
-
- Fresenius Kabi states the reason for the shortage is increased demand.
- Pfizer states the reason for the shortage is manufacturing delay.
- Sagent states the reason for the shortage is manufacturing delay.
- Sandoz has most ceftriaxone available.
- West-Ward states the reason for the shortage is manufacturing delay.
- WG Critical Care states the reason for the shortage is increased demand.
- Wockhardt has discontinued ceftriaxone as of July 2017. The 500 mg vials will be available until inventory has been depleted.
Available Products
-
Ceftriaxone injection, BBraun
1 gram/50 mL, premixed bag, 24 count (NDC 00264-3153-11)
2 gram/50 mL, premixed bag, 24 count (NDC 00264-3155-11)
Ceftriaxone injection, Baxter
1 gram/50 mL, premixed bag, 24 count (NDC 00338-5002-41)
2 gram/50 mL, premixed bag, 24 count (NDC 00338-5003-41)
1 gram/50 mL, premixed bag, 24 count (NDC 00338-5002-41)
2 gram/50 mL, premixed bag, 24 count (NDC 00338-5003-41)
Ceftriaxone injection, Fresenius Kabi
1 gram, vial, 25 count (NDC 63323-0346-10)
2 gram, vial, 10 count (NDC 63323-0347-20)
10 gram, vial, 1 count (NDC 63323-0348-61)
250 mg, vial, 25 count (NDC 63323-0344-10)
250 mg, vial, 25 count (NDC 63323-0344-10)
Ceftriaxone injection, Pfizer
1 gram, ADD-Vantage vial, 10 count (NDC 00409-7333-04)
1 gram, vial, 10 count (NDC 00409-7332-01)
2 gram, vial, 10 count (NDC 00409-7335-03)
10 gram, vial, 1 count (NDC 00409-7334-10)
250 mg, vial, 10 count (NDC 00409-7337-01)
500 mg, vial, 10 count (NDC 00409-7338-01)
2 gram, vial, 10 count (NDC 00409-7335-03)
10 gram, vial, 1 count (NDC 00409-7334-10)
250 mg, vial, 10 count (NDC 00409-7337-01)
500 mg, vial, 10 count (NDC 00409-7338-01)
Ceftriaxone injection, Sagent
1 gram, vial, 25 count (NDC 25021-0106-10)
2 gram, vial, 25 count (NDC 25021-0107-20)
10 gram, vial, 1 count (NDC 25021-0108-99)
500 mg, vial, 25 count (NDC 25021-0105-10)
Ceftriaxone injection, Samson Medical Technologies
100 gram, SmartPak bulk vial, 1 count (NDC 66288-6100-01)
100 gram, SmartPak bulk vial, 1 count (NDC 66288-6100-01)
Ceftriaxone injection, Sandoz
2 gram, vial, 10 count (NDC 00781-3209-95)
10 gram, vial, 1 count (NDC 00781-3210-46)
2 gram, vial, 10 count (NDC 00781-3209-95)
10 gram, vial, 1 count (NDC 00781-3210-46)
250 mg, vial, 10 count (NDC 00781-3206-95)
500 mg, vial, 10 count (NDC 00781-3207-95)
Ceftriaxone injection, WG Critical Care
1 gram, vial, 25 count (NDC 44567-0701-25)
1 gram, vial, 25 count (NDC 44567-0701-25)
2 gram, vial, 25 count (NDC 44567-0702-25)
10 gram, vial, 1 count (NDC 44567-0703-01)
Ceftriaxone injection, West-Ward
500 mg, vial, 25 count (NDC 00143-9858-25)
Ceftriaxone injection, Wockhardt USA
1 gram, vial, 10 count (NDC 64679-0983-02) - discontinued
500 mg, vial, 10 count (NDC 64679-0702-02) - discontinued
1 gram, vial, 10 count (NDC 64679-0983-02) - discontinued
500 mg, vial, 10 count (NDC 64679-0702-02) - discontinued
Estimated Resupply Dates
-
- Apotex has ceftriaxone 250 mg, 500 mg, 1 gram, 2 gram, and 10 gram vials on back order and the company estimates a release date of mid-July 2017 for the 1 gram, 2 gram, and 10 gram vials and early-August 2017 for the 250 mg and 500 mg vials.
- Fresenius Kabi has ceftriaxone 500 mg vials on back order and the company cannot estimate a release date.
- Lupin has all ceftriaxone presentations on allocation.
- Pfizer has ceftriaxone 2 gram ADD-Vantage vials on back order and the company estimates a release date of July 2017.
- Sandoz has ceftriaxone 1 gram vials on back order and the company estimates a release date of mid-July 2017.
- West-Ward has ceftriaxone 250 mg and 2 gram vials on back order and the company estimates a release date of July or August 2017. The 1 gram vials are on allocation.
Related Shortages
| Bacitracin Topical Ointment | Resolved |
Updated
July 10, June 9, 6 and 2, May 8 and 2, April 4, March 14, February 24, January 4, 2017; November 21 and 11, August 2, July 1, June 16, May 31, 13 and 3, April 13 and 6, March 23 and 3, February 26, January 6, 2016; December 17, November 30 and 16, October 5, September 9, August 5, July 16 and 10, June 23, 22 and 5, May 8, April 20, 16 and 8, March 10, February 20 and 3, January 9, 2015; December 12, November 26, 21, 19, 7 and 4, October 9, September 25, 15 and 4, August 21 and 6, July 21, 14 and 9, June 17 and 3, May 29, 14, 8 and 1, 2014, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
